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x. Pruritus, Pain, and Sweating Disorders 
1. PRURITUS AND PAIN 
Prevalence and Severity 
Pruritus: Itching is by far the most common symptom of skin 
diseases and may also be associated with a variety of systemic 
disorders. When localized and transient, itching is a trivial 
nuisance but, when severe and generalized, it can become 
unbearable and totally disabling. 
Eczematous diseases affect 3.5 million Americans, of whom 
1.3 million have atopic dermatitis. In this disorder, a genetically 
determined, lowered itch threshold may well represent a major 
pathogenetic factor. It has been said of atopic dermatitis that 
" It is the itching that is eruptive, not the eruption that itches," 
implying that were itching prevented the disease could not 
occur or, if present, would rapidly clear. 
A number of systemic disorders are sometimes associated 
with generalized itching. Two recent Scandinavian surveys have 
indicated that 1.5 to 3.0% of pregnant women develop significant 
itching. A 3% incidence of generalized itching in diabetics has 
been frequently cited; however, this estimate is based on a 
single study conducted more than 50 years ago. In polycythemia 
vera, severe generalized itching particularly after bathing, oc-
curs in 10-30% of patients and may be the most disabling 
featw'e of the disease. Patients with lymphomas, especially 
Hodgkin's disease, frequently complain of intractable, general-
ized itching. It has been estimated that 30% may be so affected. 
Itching usually accompanies obstructive biliary disease and, in 
fact, may precede the development of jaundice by a year or 
longer. The number of patients with chronic renal failure un-
dergoing hemodialysis is estimated at 30,000 throughout the 
United States. Of these, more than 50% complain of itching of 
variable severity, and in many the itching can be so severe as 
to be totally disabling. Generalized itching without primary 
cutaneous disease and without demonstrable systemic cause is 
not uncommon, particularly in the elderly. 
Annual sales of topical antipruritic agents approximate $11 
million, excluding about $100 million worth of topical cortico-
steroid preparations, sold annually, most of which are employed 
in the treatment of disorders in which itching is a prominent 
symptom. 
Pain: Acute infections are the most common skin condition 
associated with pain. These present no particular problem since 
effective therapy is readily available. A more grave disorder is 
postherpetic neuralgia, a complication of herpes zoster which, 
when severe and prolonged, can be totally disabling. The annual 
incidence of herpes zoster has been estimated at about 2 per 
1000: 400,000 cases in the United States each year. More than 
60% of the patients are more than 45 years of age, and there 
appears to be an increased incidence between 60 and 70. Herpes 
zoster is even more common in patients with lymphoma or 
leukemia. In one study 9% of patients with Hodgkin's disease 
developed this complication. 
The most frequent complication of herpes zoster is posther-
petic neuralgia. This is uncommon in patients less than 50 years 
of age. Between the ages of 50-59, the incidence of this compli-
cation is 18%, from 60-69 it is 37%, over 70 it is almost 50%. The 
older the patient, the longer the duration of the pain. In almost 
half the patients over 70 pain lasts for more than one year and 
in many it may persist indefinitely. If a branch ofthe trigeminal 
nerve is involved, the likelihood of postherpetic neuralgia is still 
greater. According to a Mayo Clinic study, which may not be 
entirely representative, postherpetic neuralgia of more than one 
year's duration affects about 85,000 new patients annually. 
Since the disorder tends to last indefinitely, the actual number 
of sufferers must be many times this figure. 
It is difficult to give a cost estimate of the more than 100,000 
victims of postherpetic neuralgia. Most are totally disabled and 
the symptoms so distressing that suicidal attempts are not rare. 
Prevention, Treatment, and Cure 
Prllritis: When itching occurs as a symptom of systemic 
disease (chronic renal failure , lymphoma, cholestasis, hyperthy-
roidism), it usually fades or disappears entirely as treatment for 
the underlying condition becomes effective. Certain therapeutic 
maneuvers may hasten the desirable outcome. In chronic renal 
failUTe treatments consist of exposure of the skin to short-wave 
ultraviolet light, low protein diet, or treatment of associated 
secondary hyperparathyroidism. In cholestasis treatments con-
sist of administration of cholestyramine, administration of im-
. munosuppressants, and biliary drainage procedures. 
Since itching is a symptom of a variety of cutaneous disorders, 
its control can best be accomplished by removal or alleviation 
of the underlying cause. In some instances prevention can be 
quite simple, as, for example, the use of chemicals to repel 
biting insects. In other cases, such as atopic dermatitis, the 
cause of the intractable itching is poorly understood and is 
probably due to many factors. Generalized pruritus in the 
absence of definable cutaneous or systemic causes presents an 
even more formidable problem because the underlying mecha-
nisms are completely unknown. 
In a small percentage of cases in which itching is histamine-
mediated, as in urticaria, treatment with oral antihistamines is 
usually effective. In nonhistamine-mediated skin disorders, 
antihistamines are probably no more effective than sedatives 
and yet are widely used . 
In most disorders associated with itching, treatment must be 
directed toward relief of inflammation. In these cases cortico-
steroids, both topical and systemic, are the mainstay of treat-
ment. In no case, however, can they be considered curative. 
Cure results only in inherently self-limited disorders and these 
are clearly in the minority. 
The lack of effectiveness of antipruritic therapy can be at-
tested to by the enormous number of disparate therapies avail-
able. The physician has relatively little to offer. He can pre-
scribe baths, wet dressings or lotions containing camphor, 
phenol, or menthol that substitute the sensation of cold for 
itching. An occasional patient will respond, for reasons un-
known, to topical crotamiton, a scabicide, or to thiabendozle, 
an helminthicide, although the itch is due to reasons other than 
scabies or creeping eruption. Although topical anesthetics, such 
as benzocaine or dephenhydramine, can reduce the intensity of 
itching, these and related compounds produce allergic contact 
dermatitis in some users. 
Many nonspecific, largely sedative measures have been rec-
ommended, such as bed rest, mild tranquilizers, and avoidance 
of rough clothing, overheating, alcohol, coffee, and hot foods. 
These are generally of little value. Those who consider itching 
a type of mild pain prescribe aspirin; the usefulness of aspirin 
is equivocal. 
At present there is a paucity of research on itching and 
scratching. Discovery and characterization of the cutaneous 
receptor, understanding of the complex pattern of nerve im-
pulses that are interpreted as itch, and greater knowledge of 
the biochemical events that take place within or around the 
nerve endings would spur the development of methods to 
control the symptoms. 
Until recently, the usefulness of ultraviolet light for uremic 
itching was unsuspected. Perhaps this simple form of therapy 
will prove useful in other types of generalized itching. Wide 
gaps exist in oUT knowledge of the potential effectiveness of 
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acupuncture, transcutaneous nerve stimulation, and other elec-
trophysiological and psychological approaches. Although un-
likely to be curative, it is possible that further development of 
these incompletely explored methods could well lead to more 
effective means of control. 
Pain: The patient with chronic pbstherpetic neuralgia is a 
therapeutic challenge. However, there is evidence that this 
complication may be preventable. Clinical studies indicate that 
oral corticosteroids given during the acute eruption significantly 
reduce the incidence of postherpetic neuralgia. Once the neur-
algia is well-established, relief of pain is not easily achieved. 
Narcotics, although effective, canoy a substantial risk of addic-
tion since they must be used several times daily for prolonged 
periods. Several phenothiazine tranquilizers can provide consid-
erable relief in some patients; significant untoward side effects 
often limit their use. In general, topical agents are of no value. 
Light freezing of the skin with Freon spray may occasionally be 
beneficial for weeks or months. The injection of long-acting 
corticosteroids into the skin has been claimed to be effective; 
no objective data are available to support the claim. Neurosur-
gical intervention may give relief but it is often followed by pain 
within a few months. 
As with itch, the mechanism of cutaneous hyperalgesia has 
been incompletely defined. However, it is now known that 
damage to the skin leads to the local release or synthesis of 
pain-producing substances (PPS). Antidromic stimulation of 
pain nerve fibers leads to the release of pain-intensifying sub-
stances (PES). Chemical characterization of these substances 
and their biosynthesis could lead to the identification or devel-
opment of specific inhibitors. Further clarification of the events 
occuring at the level of the frrst sensory relay nuclei would 
undoubtedly lead to improved electro physiologic techniques for 
modifying the pain responses. 
In herpes zoster, the causative virus lies dormant in the nerve 
ganglion until some precipitating factor(s) lets it propagate 
down the nerve fiber into the skin. In at least some cases the 
precipitating event is decreased immunity. This implies that an 
increase of immunity in highly susceptible persons (the elderly, 
Hodgkin's disease) may be effective in preventing this disorder 
and hence its complications. 
The human skin is permeated by small nerves subserving the 
sensations of itch and pain. Since these nerves are not visible in 
routine histologic examination, their possible participation in 
disease processes has often been overlooked. Although meth-
ylene blue, silver stains, and cholinesterase reactions have been 
used to demonstrate abnormalities in the past, these techniques 
are too insensitive to detect subtle changes in nerve endings. 
Therefore, electron microscopy is the only morphological tool 
available for the examination of the nerve endings in the skin 
responsible for pain and itch. 
Sensory nerves in the skin consist of two types: free nerve 
endings and those supplying organized receptors (Pacinian cor-
puscles, Meisner corpuscles, hair follicle end-organs and Pinkus' 
touch spots) . Organized receptors are believed to be specific 
mechanoreceptors whereas free nerve endings are believed to 
subserve pain, itch, and other sensations. 
The light microscopic term "free ending" indicates an absence 
of corpuscular structures surrounding th~ ending. Electron mi-
croscopic examination reveals however, that the axon is not 
"free." It is enclosed with a Schwann cell and basal-lamina 
throughout its course. The subepidermal horizontal network of 
nerve endings originates from nonmyelinated nerve fibers. 
Their point of origin is near the perikaryon of the terminal 
Schwann cell of the nerve sheath from which the endings 
emerge in a penicellate configuration. No specialized areas 
occUJ" at the terminal of the axon; bulbous enlargements that 
might be such specialized areas are present infrequently along 
the length of the axon. The anatomic site of pain or itch 
reception is, as yet, unknown. 
Intraepidermal nerve endings, frequently observed by light 
micl"Oscopists, have been assumed to be relevant to both pain 
and itching. However, with electron microscopy, intraepidermal 
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nerves are rarely encountered suggesting their alleged function 
may be an incorrect assumption. 
The primary reason for classifying itch as a separate sensory 
modality is that an itch feels different from any other sensation. 
It can be experienced in all gradations without other sensations 
intruding and provokes the desire to scratch. Itching can be 
produced by physical, chemical, mechanical, thermal, and elec-
trical stimuli. Spots on the skin sensitive to itch can be dem-
onstrated by mechanical pressure of a fine probe. Heat can 
produce itch if applied long enough at a nonpainful level. 
Monophasic square-wave electrical stimulation yields a repro-
ducible itch response. In the induction of suction blisters, a 
mild-to-moderate itching occurs following the application of 
negative pressure. The sensation stops instantly if suction is 
interrupted and disappears abruptly when epidermal separation 
occurs. Itching may be the frrst sign of decompression sickness. 
This so-called "diver's itch" is thought to be due to the accu-
mulation of microbubbles of nitrogen within the skin that either 
causes release of histamine or directly stimulates cutaneous 
nerves. 
Numerous acids, alkalis and other nonspecific initants can 
produce itching. Methyl bromide, for example, applied to nor-
mal skin sequentially produces itch, burning pain, and deep 
aching pain. The intradermal injection of histamine causes 
itching; intravenous injection does not. Spicules of cowage 
obtained from the pods of Mucuna pruriens produce severe 
itching when imbedded in the skin. These spicules contain an 
endopeptidase. Other peptidases, such as trypsin, chymotryp-
sin, and pepsin, are also potent pruritogens. Since all produce 
itching in the absence of a wheal and flare reaction and all are 
active in areas of skin depleted of histamine, the mechanism of 
itching produced by peptidases must be quite dissimilar to that 
induced by histamine. Dihydroxy bile salts applied to the skin 
under occlusion at acid pH produce itching; this itching is 
probably not due to histamine release. Because of the diverse 
nature of the known puritogenic stimuli it appears unlikely that 
a single mechanism subserves the itching response. 
Attempts to identify the peripheral itch receptor or receptors 
have been numerous. Some investigators have concluded that 
itch is subserved by a C-fiber receptor population. However, 
data, derived from cat cutaneous nerve strands, do not exclude 
the possibility that the "itch sensation" arises from A-fiber 
activity. Histamine-induced itching remains constant until just 
before the skin becomes analgesic owing to asphyxia or cooling; 
this is consistent with the C-fiber theory. The delay in sensory 
response to itch produced by electrical stimulation also supports 
the C-fiber theory. On the other hand, two types of itch sensa-
tion have been reported as arising from different fibers: a 
"prickling itch," caused by myelinated fibers, and a "burning 
itch" caused by nonmyelinated fibers. Thus, there is no proof 
that itch is transmitted exclusively by C-fibers. 
In the past, itch has sometimes been regarded as simply a 
type of weak pain. Considerable evidence negates this concept 
even though both itch and pain sensations are absent in patients 
with congenital indifference to pain. For example, itch and pain 
can both be experienced through a full range of intensities 
simultaneously in the same area and be separately recognized. 
Heating the skin abolishes itch and heightens pain. Removal of 
the epidermis and upper dermis eliminates the sensation of itch 
but not the perception of pain. At the central processing level 
pain and itch also differ in that itching elicits scratching whereas 
pain induces withdrawal. Furthermore, pain can be relieved by 
morphine alkaloids that may, in fact, intensify itching. 
There is also the possibility that the sensation of itch may be 
subserved by a population of hitherto undescribed specific 
cutaneous receptors. Although cutaneous receptors have been 
carefully studied, receptors specific to pruritic stimuli have 
never been identified. They may have been overlooked because 
of technical difficulties, especially if extremely small fibers are 
involved, and because they may respond exclusively to pruritic 
substances and not to other adequate stimuli. 
Although these data tend to provide clear separation of the 
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sensations of itch and pain, there is evidence that both can be 
Suppressed by a variety of mechanical and thermal stimuli. 
Noteworthy .are studies on the "antipruritic state." The com-
mon experience that scratching or pinching the skin transiently 
relieves itch led workers to study in great detail these competing 
stimuli. Pressure and vibration even of mild intensity in addi-
tion to pain suppressed itching. Light pinpricks, even at some 
distance from histamine-induced itching, provided relief if the 
painful stimulus was induced in the same dermatome. With 
more severe pain, such as pinching the skin with forceps, 
prolonged hyperalgesia occurred that prevented itch perception 
for a prolonged period. If, however, a local anesthetic was 
injected at the site of injury, itch could again be experienced. 
Since all sensations are subjective, psychological factors may 
playa decisive role in their perception. Four major groups of 
psychological investigations have dealt with this problem. The 
ethologists, principally concerned with animal responses, have 
noted that animals scratch apparently in the absence of itching 
when in a situation that elicits two mutually exclusive behav-
iors. Typically, under such circumstances an animal does nei-
ther. Instead he stops to scratch. Similar behavioral patterns 
can, of course, be observed in man. Ethologists tend to ascribe 
scratching in animals, including man, to frustration and to 
blocking of drive states. 
Psychoanalysts tend to relate scratching behavior to 
thwarted emotions arising from psychosexual complexities or 
to anxiety due to repressed, socially unacceptable drives. They 
also consider some forms of scratching as autoeroticism or 
cutaneous masturbation. In this respect they differ from the 
ethologists who have not observed this in lower animals. 
Behaviorists have been primarily interested in the scratch-
itch-scratch cycle. When scratching is performed in response to 
itch, the reduction of the itch sensation by scratching is rein-
forced, thus increasing the likelihood of additional scratching. 
At the same time, scratching increases tissue irritability so that 
itch is more likely to recur with increased intensity. Scratching 
behavior is thus reinforced, producing a habit pattern. Interest-
ingly, a scratching response can be easily induced by Pavlovian 
conditioning so that a previous neutral stimulus can elicit 
scratching behavior in both man and animals. 
Finally, trait theorists have attributed pruritic syndromes to 
constitutional, somatotypic predispositions, a hyperirritable au-
tonomic nervous system, or to certain types of personality 
Structure. Numerous studies in this field have resulted in little 
more than conflicting theories. 
Status of Clinical Research 
Pruritus: Bile salts are well-established as the cause of cho-
lestatic itching. In this disorder the degree of itching is related 
to skin levels of bile salts and not to serum levels. Attempts to 
cause itching by systemic administration of bile salts have been 
unsuccessful. Topically, dihydroxy bile salts must be applied at 
acid pH under occlusion on stripped skin. Itching begins in 
about 18 hours, the delay reflecting the time required for 
diffusion or for the release of a secondary mediator. 
Itching does not usually accompany renal failure of recent 
origin despite its severity. In chronic azotomia, itching is a 
frequent complaint and usually responds well to adequate di-
alysis and a low protein diet. However, some patients continue 
to it<;h despite apparent chemical control and many more itch 
during the dialysis period itself. 
Although the mechanism of the pruritus is not well under-
stood, some available data are pertinent. Subtotal parathy-
roidectomy has been report.ed effective in relieving pruritus in 
patients with chronic uremia and secondary hyperparathy-
roidism; this suggests that calcium and phosphorous play are 
particularly active in the genesis of the itching. However, 
parathyroidectomy has also been shown to be effective in the 
absence of hyperparathyroidism, and pruritus may be entirely 
absent in chronic uremia with chronic hyperparathyroidism. 
Thus, the role of calcium and phosphorous in pruritus is not 
clear. The success of ultraviolet light therapy in the relief of 
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uremic pruritus is also unclear and paradoxical. Vitamin D, the 
level of which should be raised by this therapy, has been shown 
to reinduce pruritus in patients treated by subtotal parathy-
roidectomy. It is possible that histamine release also is causative 
since increased numbers of mast cells are found in the spleen, 
bone marrow, and skin of patients undergoing long-term he-
modialysis. 
There are few recent studies on pruritus in patients with skin 
disorders. One group has reported that night-scratching in 
atopic dermatitis tends to occur in introverted, neurotic indi-
viduals with substantial self-directed hostility and a strong 
tendency to avoid ambiguity, ambivalance, and conflict. 
Scratching might represent a conditioned response to itching. 
To study this, patients with lichen simplex and normal individ-
uals were conditioned to scratch in response to a tone. The 
patients conditioned more readily and extinguished more slowly 
than the controls. Patients with histories of itching dermatoses 
showed a lower threshold for the perception of an electrically-
induced itch stimulus. Clearly, these rudimentary clinical stud-
ies provide little insight into the nature of itching. 
Pain: In postherpetic neuralgia, nerve fibers in the middle 
and lower dermis are destroyed; this can be demonstrated with 
silver impregnation techniques. Corresponding fibers in the 
spinal cord degenerate and scarring may occur in the sensory 
ganglia. The result is that sensory impairment is common in 
the affected area. 
Needs for Additional Basic Research 
Pl'llritis associated with inflamed or irritated skin: The 
goals of research in this area should be to identify substances 
in inflamed skin that excite itch receptors and to fmd ways of 
reducing the concentration of such substances or of blocking 
their action on nerve endings. Following are some specific 
research recommendations. 
1. There are increased concentrations of histamine, prosta·-
glandins, kallikrein, kinins, complement components, and ca-
thepsins in itchy skin. Histamine causes itch when pricked into 
human skin. Other substances need to be studied as well in 
both normal subjects and those with inflammatory dermatoses, 
before and after pretreatment with antihistamines, 48/ 80, and 
morphine. 
2. An enzyme in cowage spicules causes intense itching in 
human skin . Cowage principle should be characterized chemi-
cally and immunologically, as it may act similarly to pruritogens 
present in itchy skin. Itchy diseased skin could then be exam-
ined to determine whether any of these cowage-like products 
are present in high enough concentrations to account for the 
itch. Anticowage antibody could be developed in animals and 
used to measure cowage-like activity in itchy human skin. 
Substances found in high concentrations in itchy skin that 
cause itch when introduced into normal skin are reasonable 
suspects as pruritogens. After identifying pruritogens it should 
be 'po~ible to devise specific therapy to reduce their concentra-
tion or to block their action at the nerve endings. . 
- 3. Is itch always the result of high concentrations of pruri-
togens acting on normal nerve endings? Or in some cases might 
there be morphologic or physiological changes in the nerve 
endings? There should be studies to define the structure and 
low threshold points of itch receptors. For example, if the skin 
of normal and atopic animals were stimulated with cowage or 
other known pruritogens, recordings of nerve activity could be 
made from single sensory neurons. After identification of low 
threshold skin areas, the sites could be biopsied and studied 
microscopically to determine whether or not there are distinct 
morphological characteristics in itchy skin. 
Pruritis in shin that appears to be normal: Itch may arise in 
uninflamed or apparently normal skin in many disease states. 
Its origin is unclear. Research should be conducted to determine 
whether itching in these diseases is the result of cutaneous 
receptor hyperactivity or central nervous system stimulation. 
In those diseases where it is clear that the itch arises at levels 
higher in the central nervous system than the skin receptors, a 
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search should be made for inhibitory transmitter substances 
that could reduce the activity of specific central neurons in-
volved in itch. 
Pain: The most pressing cutaneous pain problem is associ-
ated with postherpetic neuralgia. Why zoster patients are in 
pain is not known. It is important to provide continued support 
for research on the general neuromechanisms of pain. A search 
should be made for substances that inhibit those central neu-
rons specifically involved in zoster pain. 
At present, no animal model exists with which to study the 
underlying neural mechanisms in postherpetic neuralgia. Such 
a model should be sought. 
Needs for Additional Clinical Research 
Pruritis: Data from empirical approaches to itch therapy are 
not always collected in a systematic way, and rational judg-
ments about the efficacy of such treatments are difficult to 
make. Research should be supported for carefully controlled 
studies on the use of ultraviolet light, acupuncture, and trans-
cutaneous electrical stimulation as methods for controlling in-
tractable itch. 
Collaborative studies of dermatologists and psychologists 
should be initiated to determine whether itch can be controlled 
by reducing conflict and anxiety and by elevating the patient's 
sense of personal worth. 
Pain: Carefully designed studies should be undertaken to 
document the effectiveness of currently available therapies for 
postzoster neuralgia. Patients in the early stages of the disease, 
as well as those with healed lesions but who remain in pain, 
should be used to study the effects of oral corticosteroids, 
adenine arabinoside, local cutaneous freezing of the affected 
dermatome, local ultraviolet radiation, intracutaneous electrical 
stimulation, acupuncture, and group psychotherapy. 
2. SWEATING DISORDERS 
Prevalence and Severity 
E ffects on quality of life: Generalized sweating is the normal 
response to exercise or thermal stress by which human beings 
control their body temperature through evaporative heat loss. 
Failure of this mechanism can cause hyperthermia and death. 
Interference with t hermal sweating is a serious matter and may 
have serious consequences. 
Sweating, particularly of the palms, soles, and axillae, in 
response to emotional stimulation is also normal and is gener-
ally only a cosmetic social nuisance. However, when severe and 
persistent, emotional sweating can be a handicap to employ-
ment and may predispose to other cutaneous diseases. Exces-
sive sweating probably is a contributing factor to tinea pedis, 
which afflicts 7.5 million persons in the United States, to eczema 
of the hands, which affli cts 700,000, and to contact dermatitis 
of the feet, which afflicts countless others. 
During the summer in temperate cfimates the sweat pores 
-:an be temporarily occluded producing miliaria. The disease 
particularly affects infants and is of minor import since it 
responds readily to simple cooling of the body. However, in the 
tropics, miliaria can become a serious problem. Add to this the 
impact of severe heat stress on individuals who are not accli-
matized, to wi t, military personnel stationed in the South 
Pacific in World War II. Under these conditions of extreme 
thermal stress, miliaria, tropical anhidrot ic asthenia, heat ex-
haustion, and heat stroke can produce total disability in the 
majority of affected persons. In fact, these disorders probably 
are the leading cause of disability in United States soldiers in 
tropical theaters of operation. 
Annual sales of antiperspirants in the United States approx-
imate $500 million. These products are only marginally effective 
and have no applicability to the control of excessive sweating of 
the palms and soles. Add to this expenditures for treating 
diseases that sweating may aggravate. Approximately $100 
million is expended annually for topical corticosteroid prepa-
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rations, the major treatment for eczematous eruptions of th e 
palms and soles, and additional millions are expended for topical 
and systemic antifungal agents used in the treatment of tinea 
pedis. 
Present state: Eccrine sweat glands are largely innervated by 
unique postganglionic sympathetic fibers that release acetyl-
choline at the neuroglandular junction. However, safe dosages 
of anticholinergic drugs, either topical or systemic, are incapa-
ble of controlling excessive emotional sweating. Since thermal 
sweating constitutes the major means of heat loss in a hot 
environment, attempts to inhibit emotional sweating by sys-
temic therapy can be dangerous. Tranquilizers are effective in 
some cases although their tendency to produce drowsiness 
limits their use. The topical application of formalin or gluter-
aldehyde solu tions to the palms and soles can substantially 
inhibit sweating. However, formalin often causes allergic con-
tact dermatitis and gluteraldehyde produces an objectionable 
discoloration. The alcoholic solutions of aluminum chloride 
that have recently come into use as antiperspirants seem to be 
more effective in controlling axillary sweating than sweating on 
the palms and soles. 
Surgical removal of the major eccrine gland-bearing region 
of the axillae effectively controls sweating, a procedure not 
applicable to the palms or soles. Since the eccrine sweat glands 
receive their innervation from postganglionic sympathetic fi-
bers, cervical or lumbar sympathectomy has been advocated in 
the control of extreme sweating of the palms and soles. How-
ever, this drastic operation often produces only temporary relief 
owing to the incompleteness of the procedure. Even when 
entirely successful it leaves the skin completely dry and patients 
appear more susceptible to eczema. 
In the tropics asthenia and wide-spread miliaria can be pre-
vented if a gradual acclimatization program can be instituted 
or if an air-conditioned environment is available for 8 hours 
daily. N either of these is possible in the rapid deployment of 
military personnel from a temperate to a tropical climate. 
Prospects for the future: Although our understanding of 
sweating mechanisms is far from clear, we know more about 
thermal sweating responses than emotional sweating responses. 
What is lacking is knowledge of events at the neuroglandular 
junction different iating emotional and thermal response. Exist-
ing technology is sufficiently developed to deal wit h this prob-
lem. Given a concentration of resources and study in this area, 
effective control of emotional sweating could be achieved. 
Status of Basic Research 
Man has about 3 to 4 million eccrine sweat glands, each 
weighing 30 to 40 mg. These glands are distributed throughout 
the skin and have an aggregate weight of about one kidney. 
Together these glands can secrete a maximum rate of 2-3 li ters/ 
hr for several hours in an acclimatized individual. 
Anatomically, the eccrine sweat gland consists of three major 
portions-a secretory coil, a duct and an intraepidermal sweat 
duct unit. The secretory coil produces a plasma-like precursor 
fluid . As this fluid passes through the distal portion of the duct, 
sodium is absorbed and the resulting hypotonic fluid passes 
through the proximal duct and the intraepidermal sweat duct 
unit onto the skin surface where it evaporates and cools the 
skin . 
Functionally, eccrine glands appear to be of two types: those 
thermally responsive and those emotionally responsive. Eccrine 
glands on the general body surface respond primarily to thermal 
stress and regulate body temperatme. Those on the palms and 
soles respond in addition, to emotional stimulation or direct 
pressure. These are analagous to the sweat glands on the 
friction surfaces of lower mammals. Embryologically, emotion-
ally responsive sweat glands make their appearance during the 
third fetal month and thermally responsive glands during the 
fifth. Thermally responsive glands seem to be a uniquely human 
adaptive response. Unique among mammals, man with his 
relatively naked skin, relies on evaporation rather than insula-
Nov. 1979 
tion or panting for protection against a hot environment. Among 
the primates man has evolved the most thermally responsive 
eccrine sweat gland system. 
The secretory coil of the eccrine sweat gland of the human, 
the monkey, the cat, and the opossum consists of three distinct 
cell types: the secretory, clear (or large, pale) cell; the dark (or 
mucoid) cell; and the myoepithelial cell. Substantial evidence 
indicates that the clear cell produces the aqueous component 
of sweat and the dark cell the mucoprotein component. Inter-
spersed among adjacent clear cells are intercellular canaliculi 
that open into the lumen of the secretory coil. Within the 
canaliculus the position of the "tight junction" in relation to 
the lumen confers upon this system the characteristics of a 
"backward transporting system." The myoepithelial cell func-
tions mainly as a supportive structure for the delicate secretory 
apparatus although it is capable of contractions when stimu-
lated by acetylcholine. This contraction is not essential for 
either sweat formation or expulsion since calcium ionophore 
will induce active sweating when the myoepithelial cell is ab-
sent. 
The control center for thermal sweating resides in the hypo-
thalamic area of the brain which, in effect, functions as a 
biologic thermostat. Efferent impulses descend through the 
brain stem and spinal tract, cross at various levels, and termi-
nate in the lateral horn. Sympathetic postganglionic C fibers 
abundantly innervate the secretory coil, which pharmacologi-
cally reacts as if it were mainly parasympathetic or cholinergic. 
Histochemical techniques have recently identified a loose net-
work of nerves containing catecholamine around the eccrine 
glands of the macaque. A similar dual innervation probably 
supplies the human eccrine glands as well, since they are 
responsive to both cholinergic and aru·energic stimulation. 
Although data from innumerable studies on the function of 
the sweat gland in vivo are available, our present understanding 
is also based on results obtained from experiments on isolated 
glands in vitro. These studies indicate that sweating induced 
by acetylcholine is completely inhibited not only by parasym-
patholytic agents, such as atropine, but also by ouabain. This 
indicates that Na+ + K+ - activated ATPase plays a major role 
in sweat secretion. Ouabain also inhibits glucose utilization by 
the eccrine secreting coil, which suggests a linkage of energy 
production and sodium transport. 
Samples obtained by micropuncture directly. from the secre-
tory lumen indicate that the sodium and potassium concentra-
tions are approximately isotonic to plasma. Specimens from the 
proximal duct contain sodium concentrations less than 145 mM 
and potassium concentrations greater than 5 mM, indicating 
ductal reabsorption ofNa+ and possibly the secretion ofK+ into 
the sweat. 
DibutyrylcyclicAMP, (DBcAMP) although ineffective in in-
ducing sweating in vivo upon intracutaneous injection, pro-
duces, in vitro, a sweat rate about one-tenth that of acetylcho-
line. The addition of theophylline, a phosphodiesterase inhibi-
tor, markedly increases the response to DBcAMP; the addition 
of epinepherine to BcAMP has no consistent effect. Theophyl-
line, per se, can stimulate sweating, an effect not blocked by 
either atropine or phentolamine. Prostglandin E, also induces 
active sweating at a rate equal to that of cholinergic stimulation. 
As in other glandular epithelia, calcium appears to be a 
critical element in sweat secretion. Sweating is totally inhibited 
in isolated glands in vitro by a calcium-free medium or by the 
removal of calcium from the medium by chelation with EDT A. 
Calcium ionophore, A23187, stimulates sweat secretion, an ef-
fect blocked by ouabain but not by atropine or propranolol. 
Thus, intracellular calcium stimulates the secretory process at 
a point beyond the site of action of cholinergic or adrenergic 
drugs. In fact, the primary function of acetylcholine may be the 
introduction of calcium into the cell. However, intracellular 
cAMP levels do not rise after A23187 is added to the medium, 
leaving unsolved the problem of how active transport is stimu-
lated when only calcium is introduced into the cell. 
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To maintain its secreting function the sweat gland requires 
an energy supply. Glycogen within the secretory cells is appar-
ently not a sufficient energy source since sweating in isolated 
glands does not occur in a glucose-free medium. Dependence 
on glucose does not decrease with acclimatization. The sweat 
glands in acclin1atized persons contain little glycogen and yet 
are capable of producing a higher rate of sweating than glyco-
gen-rich glands of unacclimatized persons. Degradation of glu-
cose may occur in the secretory cells by four pathways: by 
incomplete oxidation to lactate via the Embden-Meyerhof gly-
colytic cycle; by the tricarboxylic acid cycle preceded by the 
production of pyruvate; by the oxidation reactions of the hexose 
monophosphate shunt; and by oxidation to the glucuronic acid. 
Some contend that anaerobic glycosis of glucose to lactate is 
the only energy source because studies were unable to detect 
consummation of oxygen by the isolated sweat gland. Other 
evidence is to the contrary: occlusion of the blood supply to an 
extremity markedly inhibits sweating and raises sweat lactate 
concentration; sweat glands isolated for study show high CO2 
production that can be arrested by cyanide, ouabain or atropine; 
3, 4-dinitrophenol fully reverses the inhibition of glucose me-
tabolism induced by ouabain. 
The process of reabsorption of N a + from the distal sweat 
duct seems to involve active transport since Na+ + K+ - ATPase 
have been demonstrated in the duct and since ouabain inhibits 
NaCI absorption. Furthermore, the transepithelial potential 
difference is from 40 to 70 mv, lumen negative, in the duct, 
indicating that Na+ must be transported against both an elec-
trical and chemical concentration gradient. Incomplete data 
indicate that both H+ - Na+ and Na+ - K+ exchange mechanisms 
are involved in ductal reabsorption. Na+ for K+ exchange is 
facilitated by aldosterone and inhibited by aldactone. However, 
unlike the renal tubuli, antidiuretic hormone has no effect on 
ductal functions either in vivo or in vitro. 
Status of Clinical Research 
Most of the current research on eccrine sweat gland function 
is conducted by environmental physiologists concerned with 
the role of sweating in body temperature regulation during 
work and heat exposure. Although these studies are important 
in their own right, work is also needed to provide insight into 
the control of emotional sweating, which is a major factor in 
predisposing the skin, particularly the skin of the feet, to 
infections and eczema. 
Dermatologists have attempted to control emotional sweat-
ing through the use of. tranquilizers. They may afford relief, 
particularly in mild cases. Theoretically, the administration of 
anticholinergic drugs systemically should be effective, but in 
practice, these drugs tend to produce serious side effects even 
before appreciable decrease in sweating takes place. Available 
topical anticholinergic agents penetrate the skin of the palms 
and soles poorly and are, therefore, of no value. Although 
sporadic success has been reported for the use of iontophoresis, 
it enjoys little popularity. Tanning agents, such as formalde-
hyde and glutaraldehyde, definitely reduce palmar and plantar 
sweating, but the former is a contact sensitizer and the latter 
discolors the skin. Sympathectomy, when successful, simply 
substitutes an excessively ru·y skin for an excessively wet one; 
both are equally predisposed to disease. 
Needs for Additional Basic Research 
The sweat gland is accessible and physiologically manipulable 
in vivo. Sweat glands can be dissected alive from fresh skin 
biopsies for in vitro study. Basic studies should continue to be 
supported on the normal gland, both in vivo and in vitro. Such 
studies will provide not only further insight into secretory and 
reabsorptive processes within the gland but also new informa-
tion about transport mechanisms and membrane function in 
general. The results from these studies may then be extrapo-
lated to many other organs, such as the pancreas, salivary 
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gla nds, stom ach, and intestine. F urther d efinition of the physi-
ology of the eccrine sweat duct may provide insight into the 
bas ic systemic defect in cystic fibrosis in which the decreased 
ductal reabsorption of sodium is a characteristic feature. It is 
no t known why sweat glands are hyperactive in some persons. 
Studies s hould be pursued to determine if hype ractivity is the 
result of increased sensitivity at the sweat gland itse lf or at 
some m ore central level. 
Needs for Additional Clinical Research 
Hyperhidrosis is a problem on the palms, soles, and axillae of 
many persons. Despite the enormous investments by industry 
there is no safe a nd e ffective topical agent to reduce sweating. 
Attempts to find out whether the source of hyperhidrosis is 
central or peripheral should continue. Efforts to develop more 
effective systemic and topical agents for control of this signifi-
can t problem should be made. 
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